Indication
Chronic obstructive pulmonary disease with bronchospasms
Chronic obstructive pulmonary disease with bronchospasms refers to a clinical state in patients with underlying chronic obstructive pulmonary disease (COPD) who experience acute or variable constriction of bronchial smooth muscle. Read more about Chronic obstructive pulmonary disease with bronchospasms
59 drugs 48 manufacturers
Drugs that treat it
Common Chronic obstructive pulmonary disease with bronchospasms therapies.
THEO-24 (theophylline anhydrous)
IPRATROPIUM-ALBUTEROL (ipratropium bromide/albuterol sulfate)
THEOPHYLLINE (theophylline anhydrous)
THEOPHYLLINE (theophylline anhydrous)
THEOPHYLLINE (theophylline anhydrous)
IPRATROPIUM-ALBUTEROL (ipratropium bromide/albuterol sulfate)
THEOPHYLLINE (theophylline anhydrous)
THEOPHYLLINE ANHYDROUS
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic obstructive pulmonary disease with bronchospasms refers to a clinical state in patients with underlying chronic obstructive pulmonary disease (COPD) who experience acute or variable constriction of bronchial smooth muscle.
Affecting primarily adults with persistent airflow limitation due to chronic bronchitis, emphysema, or prolonged exposure to noxious particles, this condition targets the lower respiratory tract.
It is pathophysiologically characterized by acute narrowing of the conducting airways layered upon chronic airway remodeling, mucosal inflammation, and hyperinflation.
Clinically, these bronchospasms manifest as acute or episodic exacerbations of dyspnea, audible wheezing, chest tightness, and diminished expiratory airflow.
- nih.gov
Chronic obstructive pulmonary disease with bronchospasms refers to a clinical state in patients with underlying chronic obstructive pulmonary disease (COPD) who experience acute or variable constriction of bronchial smooth muscle
- clevelandclinic.org
Chronic obstructive pulmonary disease with bronchospasms refers to a clinical state in patients with underlying chronic obstructive pulmonary disease (COPD) who experience acute or variable constriction of bronchial smooth muscle It is pathophysiologically characterized by acute narrowing of the conducting airways layered upon chronic airway remodeling, mucosal inflammation, and hyperinflation Clinically, these bronchospasms manifest as acute or episodic exacerbations of dyspnea, audible wheezin...
- nih.gov
Affecting primarily adults with persistent airflow limitation due to chronic bronchitis, emphysema, or prolonged exposure to noxious particles, this condition targets the lower respiratory tract It is pathophysiologically characterized by acute narrowing of the conducting airways layered upon chronic airway remodeling, mucosal inflammation, and hyperinflation Clinically, these bronchospasms manifest as acute or episodic exacerbations of dyspnea, audible wheezing, chest tightness, and diminished ...
- nih.gov
Affecting primarily adults with persistent airflow limitation due to chronic bronchitis, emphysema, or prolonged exposure to noxious particles, this condition targets the lower respiratory tract
- nih.gov
It is pathophysiologically characterized by acute narrowing of the conducting airways layered upon chronic airway remodeling, mucosal inflammation, and hyperinflation
- massgeneralbrigham.org
Clinically, these bronchospasms manifest as acute or episodic exacerbations of dyspnea, audible wheezing, chest tightness, and diminished expiratory airflow
Personalize your experience
Follow Chronic obstructive pulmonary disease with bronchospasms and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.